Protocol for Project FACT: a randomised controlled trial on the effect of a walking program and vitamin B supplementation on the rate of cognitive decline and psychosocial wellbeing in older adults with mild cognitive impairment [ISRCTN19227688]

van Uffelen, Jannique G. Z., Hopman-Rock, Marijke, Chin A Paw, Marijke J. M. and van Mechelen, Willem (2005) Protocol for Project FACT: a randomised controlled trial on the effect of a walking program and vitamin B supplementation on the rate of cognitive decline and psychosocial wellbeing in older adults with mild cognitive impairment [ISRCTN19227688]. BMC geriatrics, 5 Article No 18: 1-9. doi:10.1186/1471-2318-5-18

Author van Uffelen, Jannique G. Z.
Hopman-Rock, Marijke
Chin A Paw, Marijke J. M.
van Mechelen, Willem
Title Protocol for Project FACT: a randomised controlled trial on the effect of a walking program and vitamin B supplementation on the rate of cognitive decline and psychosocial wellbeing in older adults with mild cognitive impairment [ISRCTN19227688]
Journal name BMC geriatrics   Check publisher's open access policy
ISSN 1471-2318
Publication date 2005-12-23
Year available 2005
Sub-type Critical review of research, literature review, critical commentary
DOI 10.1186/1471-2318-5-18
Open Access Status DOI
Volume 5
Issue Article No 18
Start page 1
End page 9
Total pages 9
Place of publication London, England
Publisher BioMed Central
Language eng
Formatted abstract
The prevalence of individuals with cognitive decline is increasing since the number of elderly adults is growing considerably. The literature provides promising results on the beneficial effect of exercise and vitamin supplementation on cognitive function both in cognitively healthy as well as in the demented elderly.

The design is a two-by-two factorial randomised controlled trial. The study population consists of independently living elderly, between 70 and 80 years old, with mild cognitive impairment (MCI). In the RCT the effect of two interventions, a walking program and vitamin supplementation, is examined. The walking program (WP) is a group-based program aimed at improving cardiovascular endurance; frequency two lessons a week; lesson duration one hour; program duration one year. Non-walking groups receive a placebo activity program (PAP) (i.e. low intensive non-aerobic group exercises, like stretching) with the same frequency, lesson and program duration. Vitamin supplementation consists of a single daily vitamin supplement containing 50 mg B6, 5 mg folic acid and 0,4 mg B12 for one year. Subjects not receiving vitamin supplements are daily taking an identically looking placebo pill, also for a year. Participants are randomised to four groups 1) WP and vitamin supplements; 2) WP and placebo supplements; 3) PAP and vitamin supplements; 4) PAP and placebo supplements. Primary outcome measures are measures of cognitive function. Secondary outcomes include psychosocial wellbeing, physical activity, cardiovascular endurance and blood vitamin levels.

No large intervention study has been conducted yet on the effect of physical activity and vitamin supplementation in a population-based sample of adults with MCI. The objective of the present article is to describe the design of a randomised controlled trial examining the effect of a walking program and vitamin B supplementation on the rate of cognitive decline in older adults with MCI.
References * Petersen, RC; Doody, R; Kurz, A; Mohs, RC; Morris, JC; Rabins, PV; Ritchie, K; Rossor, M; Thal, L; Winblad, B. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58:1985–1992. doi: 10.1001/archneur.58.12.1985. [PubMed] * Ganguli, M; Dodge, HH; Shen, CY; DeKosky, ST. Mild cognitive impairment, amnestic type - An epidemiologic study. Neurology. 2004;63:115–121. [PubMed] * Jungwirth, S; Weissgram, S; Zehetmayer, S; Tragl, KH; Fischer, P. VITA: subtypes of mild cognitive impairment in a community-based cohort at the age of 75 years. International Journal of Geriatric Psychiatry. 2005;20:452–458. doi: 10.1002/gps.1311. [PubMed] * Petersen, RC; Smith, GE; Waring, SC; Ivnik, RJ; Tangalos, EG; Kokmen, E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303–308. doi: 10.1001/archneur.56.3.303. [PubMed] * Ritchie, K; Touchon, J. Mild cognitive impairment: conceptual basis and current nosological status. Lancet. 2000;355:225–228. doi: 10.1016/S0140-6736(99)06155-3. [PubMed] * Petersen, RC; Stevens, JC; Ganguli, M; Tangalos, EG; Cummings, JL; DeKosky, ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56:1133–1142. [PubMed] * Chertkow, H. Mild cognitive impairment. Curr Opin Neurol. 2002;15:401–407. doi: 10.1097/00019052-200208000-00001. [PubMed] * Yesavage, JA; O'Hara, R; Kraemer, H; Noda, A; Taylor, JL; Ferris, S; Gely-Nargeot, MC; Rosen, A; Friedman, L; Sheikh, J; Derouesne, C. Modeling the prevalence and incidence of Alzheimer's disease and mild cognitive impairment. J Psychiatr Res. 2002;36:281–286. doi: 10.1016/S0022-3956(02)00020-1. [PubMed] * Laurin, D; Verreault, R; Lindsay, J; MacPherson, K; Rockwood, K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol. 2001;58:498–504. doi: 10.1001/archneur.58.3.498. [PubMed] * Schuit, AJ; Feskens, EJ; Launer, LJ; Kromhout, D. Physical activity and cognitive decline, the role of the apolipoprotein e4 allele. Med Sci Sports Exerc. 2001;33:772–777. [PubMed] * Yaffe, K; Barnes, D; Nevitt, M; Lui, LY; Covinsky, K. A prospective study of physical activity and cognitive decline in elderly women: women who walk. Arch Intern Med. 2001;161:1703–1708. doi: 10.1001/archinte.161.14.1703. [PubMed] * Podewils, LJ; Guallar, E; Kuller, LH; Fried, LP; Lopez, OL; Carlson, M; Lyketsos, CG. Physical activity, APOE genotype, and dementia risk: Findings from the Cardiovascular Health Cognition Study. American Journal of Epidemiology. 2005;161:639–651. doi: 10.1093/aje/kwi092. [PubMed] * Weuve, J; Kang, JH; Manson, JE; Breteler, MMB; Ware, JH; Grodstein, F. Physical activity, including walking, and cognitive function in older women. JAMA. 2004;292:1454–1461. doi: 10.1001/jama.292.12.1454. [PubMed] * Fabre, C; Chamari, K; Mucci, P; Masse-Biron, J; Prefaut, C. Improvement of cognitive function by mental and/or individualized aerobic training in healthy elderly subjects. Int J Sports Med. 2002;23:415–421. doi: 10.1055/s-2002-33735. [PubMed] * Kramer, AF; Hahn, S; Cohen, NJ; Banich, MT; McAuley, E; Harrison, CR; Chason, J; Vakil, E; Bardell, L; Boileau, RA; Colcombe, A. Ageing, fitness and neurocognitive function. Nature. 1999;400:418–419. doi: 10.1038/22682. [PubMed] * Williams, P; Lord, SR. Effects of group exercise on cognitive functioning and mood in older women. Aust N Z J Public Health. 1997;21:45–52. [PubMed] * Hassmen, P; Koivula, N. Mood, physical working capacity and cognitive performance in the elderly as related to physical activity. Aging (Milano ). 1997;9:136–142. [PubMed] * Tomporowski, PD; Ellis, NR. Effects of exercise on cognitive processes: a review. Psychological bulletin. 1986;99:338–346. doi: 10.1037/0033-2909.99.3.338. * van Sickle, TD; Hersen, M; Simco, ER; Melton, MA; van Hasselt, VB. Effects of physical exercise on cognitive functioning in the elderly. Int J Rehab Health. 1996;2:67–100. doi: 10.1007/BF02213444. * Etnier, JL; Salazar, W; Landers, DM; Petruzello, SJ; Myungwoo, H; Nowell, P. The influence of physical fitness and exercise upon cognitive functioning: a meta-analysis. Journal of Sports & Exercise Psychology. 1997;19:249–277. * Colcombe, S; Kramer, AF. Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol Sci. 2003;14:125–130. doi: 10.1111/1467-9280.t01-1-01430. [PubMed] * Heyn, P; Abreu, BC; Ottenbacher, KJ. The effects of exercise training on elderly persons with cognitive impairment and dementia: A meta-analysis. Arch Phys Med Rehabil. 2004;85:1694–1704. doi: 10.1016/j.apmr.2004.03.019. [PubMed] * Biddle, S; Faulkner, G. Psychological and Social Benefits of Physical Activity. In: Chan KM. , editor. Active Aging. Hong Kong, Lippinicott, Williams & Wilkins Asia Ltd.; 2002. pp. 89–164. * Churchill, JD; Galvez, R; Colcombe, S; Swain, RA; Kramer, AF; Greenough, WT. Exercise, experience and the aging brain. Neurobiol Aging. 2002;23:941–955. doi: 10.1016/S0197-4580(02)00028-3. [PubMed] * Etnier, JL; Landers, DM. Brain function and exercise. Current perspectives. Sports Med. 1995;19:81–85. [PubMed] * Baik, HW; Russell, RM. Vitamin B12 deficiency in the elderly. Annu Rev Nutr. 1999;19:357–377. doi: 10.1146/annurev.nutr.19.1.357. [PubMed] * Konings, EJ; Roomans, HH; Dorant, E; Goldbohm, RA; Saris, WH; van den Brandt, PA. Folate intake of the Dutch population according to newly established liquid chromatography data for foods. Am J Clin Nutr. 2001;73:765–776. [PubMed] * Naurath, HJ; Joosten, E; Riezler, R; Stabler, SP; Allen, RH; Lindenbaum, J. Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations. Lancet. 1995;346:85–89. doi: 10.1016/S0140-6736(95)92113-3. [PubMed] * Riggs, KM; Spiro, AIII; Tucker, K; Rush, D. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr. 1996;63:306–314. [PubMed] * Robins Wahlin, TB; Wahlin, A; Winblad, B; Backman, L. The influence of serum vitamin B12 and folate status on cognitive functioning in very old age. Biol Psychol. 2001;56:247–265. doi: 10.1016/S0301-0511(01)00079-5. [PubMed] * Kado, DM; Karlamangla, AS; Huang, MH; Troen, A; Rowe, JW; Selhub, J; Seeman, TE. Homocysteine versus the vitamins folate, B-6, and B-12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur studies of successful aging. American Journal of Medicine. 2005;118:161–167. doi: 10.1016/j.amjmed.2004.08.019. [PubMed] * Selhub, J; Jacques, PF; Wilson, PW; Rush, D; Rosenberg, IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 1993;270:2693–2698. doi: 10.1001/jama.270.22.2693. [PubMed] * Seshadri, S; Beiser, A; Selhub, J; Jacques, PF; Rosenberg, IH; D'Agostino, RB; Wilson, PW; Wolf, PA. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 2002;346:476–483. doi: 10.1056/NEJMoa011613. [PubMed] * Budge, MM; de Jager, C; Hogervorst, E; Smith, AD. Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people. J Am Geriatr Soc. 2002;50:2014–2018. doi: 10.1046/j.1532-5415.2002.50614.x. [PubMed] * Garcia, A; Zanibbi, K. Homocysteine and cognitive function in elderly people. Canadian Medical Association Journal. 2004;171:897–904. doi: 10.1503/cmaj.1031586. [PubMed] * Ravaglia, G; Forti, P; Maioli, F; Scali, RC; Sacchetti, L; Talerico, T; Mantovani, V; Bianchin, M. Homocysteine and cognitive performance in healthy elderly subjects. Arch Gerontol Geriatr. 2004:349–357. doi: 10.1016/j.archger.2004.04.045. [PubMed] * Morris, MS; Jacques, PF; Rosenberg, IH; Selhub, J. Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey. Am J Clin Nutr. 2001;73:927–933. [PubMed] * Schafer, JH; Glass, TA; Bolla, KI; Mintz, M; Jedlicka, AE; Schwartz, BS. Homocysteine and cognitive function in a population-based study of older adults. Journal of the American Geriatrics Society. 2005;53:381–388. doi: 10.1111/j.1532-5415.2005.53153.x. [PubMed] * Prins, ND; Den Heijer, T; Hofman, A; Koudstaal, PJ; Jolles, J; Clarke, R; Breteler, MM. Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study. Neurology. 2002;59:1375–1380. [PubMed] * Dufouil, C; Alperovitch, A; Ducros, V; Tzourio, C. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol. 2003;53:214–221. doi: 10.1002/ana.10440. [PubMed] * Kado, DM; Selhub, J; Seeman, TE. Plasma total homocysteine levels and cognitive function in older high functioning adults; MacArthur studies of successful aging. American Geriatric Society, Paper abstracts. 2001. p. S13. * Rydlewicz, A; Simpson, JA; Taylor, RJ; Bond, CM; Golden, MH. The effect of folic acid supplementation on plasma homocysteine in an elderly population. QJM. 2002;95:27–35. doi: 10.1093/qjmed/95.1.27. [PubMed] * Woo, KS; Chook, P; Chan, LL; Cheung, AS; Fung, WH; Qiao, M; Lolin, YI; Thomas, GN; Sanderson, JE; Metreweli, C; Celermajer, DS. Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplementation. Am J Med. 2002;112:535–539. doi: 10.1016/S0002-9343(02)01075-6. [PubMed] * Lowering blood homocysteine with folic acid based supplements: meta- analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration. BMJ. 1998;316:894–898. [PubMed] * Bryan, J; Calvaresi, E; Hughes, D. Short-term folate, vitamin B-12 or vitamin B-6 supplementation slightly affects memory performance but not mood in women of various ages. Journal of Nutrition. 2002;132:1345–1356. [PubMed] * Fioravanti, M; Ferrario, E; Massaia, M; Cappa, G; Rivolta, G; Grossi, E; Buckley, AE. Low folate levels in the cognitive decline of elderly patients and the efficacy of folate as a treatment for improving memory deficits. Arch Gerontol Geriatr. 2002;26:1–13. doi: 10.1016/S0167-4943(97)00028-9. * van Asselt, DZ; Pasman, JW; van Lier, HJ; Vingerhoets, DM; Poels, PJ; Kuin, Y; Blom, HJ; Hoefnagels, WH. Cobalamin supplementation improves cognitive and cerebral function in older, cobalamin-deficient persons. J Gerontol A Biol Sci Med Sci. 2001;56:M775–M779. [PubMed] * Nilsson, K; Gustafson, L; Hultberg, B. Improvement of cognitive functions after cobalamin/folate supplementation in elderly patients with dementia and elevated plasma homocysteine. Int J Geriatr Psychiatry. 2001;16:609–614. doi: 10.1002/gps.388. [PubMed] * Calvaresi, E; Bryan, J. B vitamins, cognition, and aging: a review. J Gerontol B Psychol Sci Soc Sci. 2001;56:P327–P339. [PubMed] * Strawbridge, WJ; Shema, SJ; Balfour, JL; Higby, HR; Kaplan, GA. Antecedents of frailty over three decades in an older cohort. J Gerontol B Psychol Sci Soc Sci. 1998;53:S9–16. [PubMed] * Kempen, GI; Miedema, I; Ormel, J; Molenaar, W. The assessment of disability with the Groningen Activity Restriction Scale. Conceptual framework and psychometric properties. Soc Sci Med. 1996;43:1601–1610. doi: 10.1016/S0277-9536(96)00057-3. [PubMed] * Brandt, J; Spencer, M; Folstein, M. The Telephone Interview for Cognitive Status. Neuropsychiatry, Neuropsychology and Behavioral Neurology. 1988;1:111–117. * Morris, JC; Heyman, A; Mohs, RC; Hughes, JP; van Belle, G; Fillenbaum, G; Mellits, ED; Clark, C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989;39:1159–1165. [PubMed] * Welsh, KA; Butters, N; Mohs, RC; Beekly, D; Edland, S; Fillenbaum, G; Heyman, A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology. 1994;44:609–614. [PubMed] * Stel, VS; Smit, JH; Pluijm, SMF; Visser, M; Deeg, DJH; Lips, P. Comparison of the LASA Physical Activity Questionnaire with a 7-day diary and pedometer. Journal of Clinical Epidemiology. 2004;57:252–258. doi: 10.1016/j.jclinepi.2003.07.008. [PubMed] * Stahl, T; Laukkanen, R. A way of healthy walking - A guidebook for health promotion practice. 2000. * Folstein, MF; Folstein, SE; McHugh, PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198. doi: 10.1016/0022-3956(75)90026-6. [PubMed] * Rey, A. L'examen clinique en psychologie. Paris, Presses Universitaires de France; 1964. * Lezak, MD. Neuropsychological assessment. 3rd. New York, Oxford University Press, Inc.; 1995. * Uiterwijk, JM. WAIS-III-NL/V. Lisse, Swets & Zeitlinger; 2001. * Klein, M. Cognitive Aging, Attention, and Mild Traumatic Brain Injury. Universiteit Maastricht; 1997. pp. 95–105. * de Jonghe, JF; Schmand, B; Ooms, ME; Ribbe, MW. [Abbreviated form of the Informant Questionnaire on cognitive decline in the elderly]. Tijdschr Gerontol Geriatr. 1997;28:224–229. [PubMed] * Jorm, AF. A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Psychol Med. 1994;24:145–153. [PubMed] * Ware, JE; Kosinski, M; Keller, SD. SF-12: How to score the SF-12 physical and mental health summary scales. Second edition. Boston, MA, The health institute, New England Medical Center; 1995. * Brod, M; Stewart, AL; Sands, L; Walton, P. Conceptualization and measurement of quality of life in dementia: the dementia quality of life instrument (DQoL). Gerontologist. 1999;39:25–35. doi: 10.1159/000026556. [PubMed] * EuroQol--a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy. 1990;16:199–208. doi: 10.1016/0168-8510(90)90421-9. [PubMed] * Yesavage, JA; Brink, TL; Rose, TL; Lum, O; Huang, V; Adey, M; Leirer, VO. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17:37–49. doi: 10.1016/0022-3956(82)90033-4. [PubMed] * Lemmink, K. De Groninger fitheidstest voor ouderen: ontwikkeling van een meetinstrument. Rijksuniversiteit Groningen; 1996.
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Journal Article
Sub-type: Critical review of research, literature review, critical commentary
Collections: Excellence in Research Australia (ERA) - Collection
School of Human Movement and Nutrition Sciences Publications
Version Filter Type
Citation counts: Scopus Citation Count Cited 13 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Fri, 09 Jan 2009, 19:25:25 EST by Judy Dingwall on behalf of Faculty Of Health Sciences